DXR's logo.
Ticker Symbol: DXR

Daxor Corp.

$10.99 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0000027367

Company Profile

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations). Daxor Corporation developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor's vision is optimal blood volume for all.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: www.daxor.com
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $8.92
Change: -$0.10 ( -1.11%)
Days Range: $8.92 - $9.05
Beta: -
52wk. High: $13.34
52wk. Low: $7.81
Ytd. Change -3.73%
50 Day Moving Average: $9.36
200 Day Moving Average: $10.05
Shares Outstanding: 4734987

Valuation

Market Cap: 4.2B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A